Short Interest in Edap Tms SA (NASDAQ:EDAP) Grows By 30.1%

Edap Tms SA (NASDAQ:EDAP) was the recipient of a large increase in short interest in September. As of September 30th, there was short interest totalling 51,900 shares, an increase of 30.1% from the August 30th total of 39,900 shares. Based on an average trading volume of 191,400 shares, the short-interest ratio is currently 0.3 days. Approximately 0.2% of the shares of the company are short sold.

Several equities analysts have commented on the company. ValuEngine cut Edap Tms from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Zacks Investment Research raised Edap Tms from a “hold” rating to a “strong-buy” rating and set a $4.25 price target for the company in a report on Friday, September 6th. HC Wainwright set a $7.00 price target on Edap Tms and gave the company a “buy” rating in a report on Friday, August 30th. Finally, TheStreet cut Edap Tms from a “b-” rating to a “d+” rating in a report on Monday, June 17th.

Shares of EDAP traded down $0.10 during mid-day trading on Monday, reaching $4.52. The company had a trading volume of 154,020 shares, compared to its average volume of 180,480. Edap Tms has a twelve month low of $1.35 and a twelve month high of $5.42. The company’s 50-day moving average is $4.06 and its 200-day moving average is $3.61. The company has a market capitalization of $132.81 million, a P/E ratio of 226.00 and a beta of 1.88.

Edap Tms (NASDAQ:EDAP) last issued its earnings results on Wednesday, August 28th. The medical equipment provider reported $0.05 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.01 by $0.04. Edap Tms had a return on equity of 23.31% and a net margin of 4.57%. The business had revenue of $14.04 million during the quarter, compared to analysts’ expectations of $11.92 million. On average, equities analysts predict that Edap Tms will post 0.18 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently modified their holdings of the company. Hilton Capital Management LLC acquired a new position in shares of Edap Tms in the 1st quarter worth approximately $75,000. JPMorgan Chase & Co. acquired a new position in shares of Edap Tms in the 2nd quarter worth approximately $282,000. Susquehanna International Group LLP raised its holdings in shares of Edap Tms by 762.9% in the 2nd quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock worth $556,000 after buying an additional 181,401 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of Edap Tms in the 2nd quarter worth approximately $607,000. Finally, Morgan Stanley raised its holdings in shares of Edap Tms by 222.7% in the 2nd quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock worth $722,000 after buying an additional 184,539 shares in the last quarter. 13.24% of the stock is owned by institutional investors and hedge funds.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

Further Reading: How to start trading in the forex market?

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit